A single vectored thermal pulsation treatment for meibomian gland dysfunction increases mean comfortable contact lens wearing time by approximately 4 hours per day
Caroline A Blackie,1 Christy A Coleman,1 Kelly K Nichols,2 Lyndon Jones,3 Peter Q Chen,4 Ron Melton,5 David L Kading,6 Leslie E O’Dell,7 Sruthi Srinivasan3 1TearScience Inc., Morrisville, NC, 2School of Optometry, The University of Alabama at Birmingham, AB, USA; 3School of Optometry and...
Guardado en:
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2018
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/37609e941cd14254ba6460f17aa4cfb6 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:37609e941cd14254ba6460f17aa4cfb6 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:37609e941cd14254ba6460f17aa4cfb62021-12-02T02:29:33ZA single vectored thermal pulsation treatment for meibomian gland dysfunction increases mean comfortable contact lens wearing time by approximately 4 hours per day1177-5483https://doaj.org/article/37609e941cd14254ba6460f17aa4cfb62018-01-01T00:00:00Zhttps://www.dovepress.com/a-single-vectored-thermal-pulsation-treatment-for-meibomian-gland-dysf-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Caroline A Blackie,1 Christy A Coleman,1 Kelly K Nichols,2 Lyndon Jones,3 Peter Q Chen,4 Ron Melton,5 David L Kading,6 Leslie E O’Dell,7 Sruthi Srinivasan3 1TearScience Inc., Morrisville, NC, 2School of Optometry, The University of Alabama at Birmingham, AB, USA; 3School of Optometry and Vision Science, University of Waterloo, Waterloo, ON, Canada; 4Clayton Eye Center, Morrow, GA, 5Charlotte Eye Ear Nose and Throat Associates, Charlotte, NC, 6Specialty Eyecare Group, Kirkland, WA, 7May Eye Care Center and Associates, Hanover, PA, USA Purpose: To evaluate the effect of a single vectored thermal pulsation (VTP) treatment in contact lens wearers with meibomian gland dysfunction (MGD) and dry eye symptoms.Methods: The prospective, nonsignificant risk, open-label, randomized, multi-center clinical trial included 55 soft contact lens (SCL) wearers with MGD and evaporative dry eye. Subjects were randomized to the single VTP treatment group or an untreated control. The controls received a crossover VTP treatment at 3 months (crossover treatment group). Primary effectiveness measures were meibomian gland secretion (MGS) score and Standard Patient Evaluation of Eye Dryness (SPEED) that were evaluated at baseline, at 1 and 3 months post-VTP treatment, and at 1 month post-VTP treatment in the crossover treatment group. Exploratory variables included fluorescein tear break-up time (TBUT), lid wiper epitheliopathy (LWE), lid parallel conjunctival folds (LIPCOF), ocular surface staining, frequency of over-the-counter (OTC) drop use, and hours of comfortable contact lens wear.Results: At 3 months, the treatment group showed significantly greater mean change from baseline in MGS (12.4±9.1 vs 1.4±6.4, p<0.0001), SPEED (-8.4±4.7 vs -0.7±4.4, p<0.0001) and significantly greater improvement in exploratory variables (TBUT, LWE, and frequency of OTC drop use) relative to the controls. Mean comfortable contact lens wearing time increased by 4.0±3.9 hours at 1 month. This was sustained for 3 months with no change in the control group. The crossover treatment group demonstrated similar results to the treatment group at 1 month post-VTP.Conclusion: In SCL wearers with MGD, a single VTP treatment significantly improved mean meibomian gland function and significantly reduced dry eye signs and symptoms compared to an untreated control. The treatment increased mean comfortable lens wearing time by 4 hours (approximately doubling the pretreatment findings). This was sustained for up to 3 months post-treatment on average. Keywords: meibomian gland dysfunction, vectored thermal pulsation, Dynamic Meibomian Imaging, evaporative dry eye, soft contact lens wear, comfortable contact lens wearing timeBlackie CAColeman CANichols KKJones LChen PQMelton RKading DLO'Dell LESrinivasan SDove Medical PressarticleMeibomian gland dysfunctionVectored Thermal PulsationDynamic Meibomian Imagingevaporative dry eyesoft contact lens wearcomfortable contact lens wearing time.OphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 12, Pp 169-183 (2018) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Meibomian gland dysfunction Vectored Thermal Pulsation Dynamic Meibomian Imaging evaporative dry eye soft contact lens wear comfortable contact lens wearing time. Ophthalmology RE1-994 |
| spellingShingle |
Meibomian gland dysfunction Vectored Thermal Pulsation Dynamic Meibomian Imaging evaporative dry eye soft contact lens wear comfortable contact lens wearing time. Ophthalmology RE1-994 Blackie CA Coleman CA Nichols KK Jones L Chen PQ Melton R Kading DL O'Dell LE Srinivasan S A single vectored thermal pulsation treatment for meibomian gland dysfunction increases mean comfortable contact lens wearing time by approximately 4 hours per day |
| description |
Caroline A Blackie,1 Christy A Coleman,1 Kelly K Nichols,2 Lyndon Jones,3 Peter Q Chen,4 Ron Melton,5 David L Kading,6 Leslie E O’Dell,7 Sruthi Srinivasan3 1TearScience Inc., Morrisville, NC, 2School of Optometry, The University of Alabama at Birmingham, AB, USA; 3School of Optometry and Vision Science, University of Waterloo, Waterloo, ON, Canada; 4Clayton Eye Center, Morrow, GA, 5Charlotte Eye Ear Nose and Throat Associates, Charlotte, NC, 6Specialty Eyecare Group, Kirkland, WA, 7May Eye Care Center and Associates, Hanover, PA, USA Purpose: To evaluate the effect of a single vectored thermal pulsation (VTP) treatment in contact lens wearers with meibomian gland dysfunction (MGD) and dry eye symptoms.Methods: The prospective, nonsignificant risk, open-label, randomized, multi-center clinical trial included 55 soft contact lens (SCL) wearers with MGD and evaporative dry eye. Subjects were randomized to the single VTP treatment group or an untreated control. The controls received a crossover VTP treatment at 3 months (crossover treatment group). Primary effectiveness measures were meibomian gland secretion (MGS) score and Standard Patient Evaluation of Eye Dryness (SPEED) that were evaluated at baseline, at 1 and 3 months post-VTP treatment, and at 1 month post-VTP treatment in the crossover treatment group. Exploratory variables included fluorescein tear break-up time (TBUT), lid wiper epitheliopathy (LWE), lid parallel conjunctival folds (LIPCOF), ocular surface staining, frequency of over-the-counter (OTC) drop use, and hours of comfortable contact lens wear.Results: At 3 months, the treatment group showed significantly greater mean change from baseline in MGS (12.4±9.1 vs 1.4±6.4, p<0.0001), SPEED (-8.4±4.7 vs -0.7±4.4, p<0.0001) and significantly greater improvement in exploratory variables (TBUT, LWE, and frequency of OTC drop use) relative to the controls. Mean comfortable contact lens wearing time increased by 4.0±3.9 hours at 1 month. This was sustained for 3 months with no change in the control group. The crossover treatment group demonstrated similar results to the treatment group at 1 month post-VTP.Conclusion: In SCL wearers with MGD, a single VTP treatment significantly improved mean meibomian gland function and significantly reduced dry eye signs and symptoms compared to an untreated control. The treatment increased mean comfortable lens wearing time by 4 hours (approximately doubling the pretreatment findings). This was sustained for up to 3 months post-treatment on average. Keywords: meibomian gland dysfunction, vectored thermal pulsation, Dynamic Meibomian Imaging, evaporative dry eye, soft contact lens wear, comfortable contact lens wearing time |
| format |
article |
| author |
Blackie CA Coleman CA Nichols KK Jones L Chen PQ Melton R Kading DL O'Dell LE Srinivasan S |
| author_facet |
Blackie CA Coleman CA Nichols KK Jones L Chen PQ Melton R Kading DL O'Dell LE Srinivasan S |
| author_sort |
Blackie CA |
| title |
A single vectored thermal pulsation treatment for meibomian gland dysfunction increases mean comfortable contact lens wearing time by approximately 4 hours per day |
| title_short |
A single vectored thermal pulsation treatment for meibomian gland dysfunction increases mean comfortable contact lens wearing time by approximately 4 hours per day |
| title_full |
A single vectored thermal pulsation treatment for meibomian gland dysfunction increases mean comfortable contact lens wearing time by approximately 4 hours per day |
| title_fullStr |
A single vectored thermal pulsation treatment for meibomian gland dysfunction increases mean comfortable contact lens wearing time by approximately 4 hours per day |
| title_full_unstemmed |
A single vectored thermal pulsation treatment for meibomian gland dysfunction increases mean comfortable contact lens wearing time by approximately 4 hours per day |
| title_sort |
single vectored thermal pulsation treatment for meibomian gland dysfunction increases mean comfortable contact lens wearing time by approximately 4 hours per day |
| publisher |
Dove Medical Press |
| publishDate |
2018 |
| url |
https://doaj.org/article/37609e941cd14254ba6460f17aa4cfb6 |
| work_keys_str_mv |
AT blackieca asinglevectoredthermalpulsationtreatmentformeibomianglanddysfunctionincreasesmeancomfortablecontactlenswearingtimebyapproximately4hoursperday AT colemanca asinglevectoredthermalpulsationtreatmentformeibomianglanddysfunctionincreasesmeancomfortablecontactlenswearingtimebyapproximately4hoursperday AT nicholskk asinglevectoredthermalpulsationtreatmentformeibomianglanddysfunctionincreasesmeancomfortablecontactlenswearingtimebyapproximately4hoursperday AT jonesl asinglevectoredthermalpulsationtreatmentformeibomianglanddysfunctionincreasesmeancomfortablecontactlenswearingtimebyapproximately4hoursperday AT chenpq asinglevectoredthermalpulsationtreatmentformeibomianglanddysfunctionincreasesmeancomfortablecontactlenswearingtimebyapproximately4hoursperday AT meltonr asinglevectoredthermalpulsationtreatmentformeibomianglanddysfunctionincreasesmeancomfortablecontactlenswearingtimebyapproximately4hoursperday AT kadingdl asinglevectoredthermalpulsationtreatmentformeibomianglanddysfunctionincreasesmeancomfortablecontactlenswearingtimebyapproximately4hoursperday AT odellle asinglevectoredthermalpulsationtreatmentformeibomianglanddysfunctionincreasesmeancomfortablecontactlenswearingtimebyapproximately4hoursperday AT srinivasans asinglevectoredthermalpulsationtreatmentformeibomianglanddysfunctionincreasesmeancomfortablecontactlenswearingtimebyapproximately4hoursperday AT blackieca singlevectoredthermalpulsationtreatmentformeibomianglanddysfunctionincreasesmeancomfortablecontactlenswearingtimebyapproximately4hoursperday AT colemanca singlevectoredthermalpulsationtreatmentformeibomianglanddysfunctionincreasesmeancomfortablecontactlenswearingtimebyapproximately4hoursperday AT nicholskk singlevectoredthermalpulsationtreatmentformeibomianglanddysfunctionincreasesmeancomfortablecontactlenswearingtimebyapproximately4hoursperday AT jonesl singlevectoredthermalpulsationtreatmentformeibomianglanddysfunctionincreasesmeancomfortablecontactlenswearingtimebyapproximately4hoursperday AT chenpq singlevectoredthermalpulsationtreatmentformeibomianglanddysfunctionincreasesmeancomfortablecontactlenswearingtimebyapproximately4hoursperday AT meltonr singlevectoredthermalpulsationtreatmentformeibomianglanddysfunctionincreasesmeancomfortablecontactlenswearingtimebyapproximately4hoursperday AT kadingdl singlevectoredthermalpulsationtreatmentformeibomianglanddysfunctionincreasesmeancomfortablecontactlenswearingtimebyapproximately4hoursperday AT odellle singlevectoredthermalpulsationtreatmentformeibomianglanddysfunctionincreasesmeancomfortablecontactlenswearingtimebyapproximately4hoursperday AT srinivasans singlevectoredthermalpulsationtreatmentformeibomianglanddysfunctionincreasesmeancomfortablecontactlenswearingtimebyapproximately4hoursperday |
| _version_ |
1718402459523612672 |